CAGR Of 4.8%: Global Alopecia Drugs Market about to hit CAGR of 4.8% from 2017 to 2026

Global Alopecia Drugs Market about to hit CAGR of 4.8% from 2017 to 2026 The global alopecia drugs market was valued at US$ 6,901.8 Mn in 2016 and is projected to reach US$ 10,992.9 Mn in 2026 at a CAGR of 4.8% from 2017 to 2026. The topical segment in the global alopecia drugs market accounted for a major revenue share of 69.8% owing to factors such as easy absorption of medications by hair follicles, along with easier administration and application as compared to other forms.

Global Alopecia Drugs Market: Segmental Snapshot

By route of administration: The topical segment is estimated to register a CAGR of over 5.1%, thereby accounting for highest revenue share among the route of administration segments.

By gender: The men segment is estimated to account for highest revenue share among the gender segments, registering a CAGR of over 5.0% during the forecast period.

By region: The market in Asia Pacific is expected to record highest CAGR of over 7.3% between 2017 and 2026.

Global Alopecia Drugs Market: Competitive Analysis

The research report on the global alopecia drugs market includes detailed competitive analysis on major companies such as Taisho Pharmaceutical Holdings Co. Ltd., The Himalaya Drug Company, Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., MERCK, Vitabiotic Ltd., and Sun Pharmaceutical Industries Ltd. Via:

https://marketresearch.biz/infographics/global-alopecia-drugs-market-estimated-reach-us-10992-9-mn-2026/